Bluebird Bio
(NASDAQ) BLUE
This security has been delisted. This page is retained for historical reference.
BLUE News
Is Bluebird Bio Stock a Buy?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowBLUE Financials
Key Financial Metrics (TTM)
Gross Margin
54.65%
Operating Margin
-79.07%
Net Income Margin
-74.81%
Return on Equity
129.26%
Return on Capital
-82.78%
Return on Assets
-19.52%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$28.19M
Operating Income
-$216.38M
EBITDA
-$115.82M
Operating Cash Flow
-$228.79M
Capital Expenditure
-$1.68M
Free Cash Flow
-$230.47M
Cash & ST Invst.
$78.74M
Total Debt
$188.14M
Bluebird Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$38.71M
+108.4%
Gross Profit
$26.48M
+463.1%
Gross Margin
68.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
248
N/A
Net Income
-$29.07M
+58.4%
EBITDA
-$7.68M
+84.5%
Quarterly Fundamentals
Total Cash
$78.74M
-62.9%
Total Debt
$188.14M
-54.6%
Accounts Receivable
$4.06M
-77.1%
Inventory
$83.28M
+174.8%
Long Term Debt
$38.65M
-81.3%
Short Term Debt
$149.49M
-28.0%
Return on Assets
-19.52%
N/A
Return on Invested Capital
3.19%
N/A
Free Cash Flow
-$44.30M
+42.1%
Operating Cash Flow
-$43.44M
+41.8%